Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial.
Per WinkelJanus Christian JakobsenJørgen HildenGorm Boje JensenErik KjøllerAhmad SajadiehJens KastrupHans Jørn KolmosKasper Karmark IversenMette BjerreAnders LarssonJohan ÄrnlövChristian GluudPublished in: BMJ open (2020)
NCT00121550.
Keyphrases
- phase iii
- coronary artery disease
- clinical trial
- open label
- study protocol
- phase ii
- double blind
- percutaneous coronary intervention
- cardiovascular events
- placebo controlled
- coronary artery bypass grafting
- cardiovascular disease
- heart failure
- acute coronary syndrome
- type diabetes
- aortic stenosis
- aortic valve
- left ventricular
- transcatheter aortic valve replacement